Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
05/2008
05/06/2008US7368141 Precipitating casein from a product that contains lactoferrin to form a lactoferrin-casein adsorption product and subjecting the precipitate to extraction to release the lactoferrin associated with it; the extraction medium may be then subjected to different types of purification operation steps
05/06/2008US7368108 Glycopeptide remodeling using amidases
05/06/2008CA2451190C Process for extracting flax protein concentrate from flax meal
05/06/2008CA2403190C Method for separating proteins by capillary electrophoresis and buffer compositions for capillary electrophoresis
05/06/2008CA2286668C Trans-platinum compound, and diagnostic kit
05/06/2008CA2283868C Photosensitizer conjugates for pathogen targeting
05/06/2008CA2163637C Topologically segregated, encoded solid phase libraries
05/06/2008CA2125636C Process for preparing an .alpha.-amino acid amide, useful for peptidic synthesis
05/02/2008WO2008051383A2 Use of alcohol co-solvents to improve pegylation reaction yields
05/02/2008WO2008051178A2 Purification of proteins with cationic surfactant
05/02/2008WO2008049942A1 Enzymatic collagen hydrolysate and method for obtaining same
05/02/2008WO2008049262A1 A bamboo shoot amino acid peptide extract, its preparation method and its use
05/02/2008WO2007082173A3 Compositions and methods for enhancing the identification of prion protein prpsc
05/02/2008CA2608923A1 Non-metallic laboratory implement and method of its use
05/01/2008US20080103290 Eluting from polystyrene divinyl benzene resin using acidified solution containing organic solvent; antibacterial
05/01/2008US20080103061 Functionalized compositions for improved immobilization
04/2008
04/30/2008EP1916256A2 Search for cancer markers by a novel screening method
04/30/2008EP1915389A2 Differentially protected orthogonal lanthionine technology
04/30/2008EP1915388A1 F11 receptor (f11r) antagonists as therapeutic agents
04/30/2008EP1419177B1 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine
04/30/2008EP1399023B1 COMPOSITIONS FOR SYSTEMIC ADMINISTRATION OF SEQUENCES ENCODING BONE MORPHOGENETIC PROTEINS& x9;
04/30/2008EP1307486B1 Somatostatin analogues
04/30/2008EP1294747B1 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
04/30/2008EP1213297B1 Tachykinin peptides, precursor peptides thereof and genes encoding the same
04/30/2008EP1183360B1 Modified cytokine for its stabilisation
04/30/2008EP0983351B1 Nucleic acid binding proteins
04/30/2008EP0983350B1 Nucleic acid binding proteins
04/30/2008CN101171261A Immunoglobulin fraction and process therefor
04/30/2008CN101171022A Compositions and methods for inhibiting G protein signaling
04/30/2008CN101168561A Method for separating and purifying microcystin
04/30/2008CN101168559A Method for separating and purifying Chinese cabbage differential protein/isozyme
04/30/2008CN100384874C Protein a chromatography
04/30/2008CN100384872C Method for purifying mouse herve growth factor for scale-production
04/30/2008CN100384869C Diisopropoxy phosphoryl dipeptide trimethoxy benzamide compound and its preparation process
04/29/2008US7365178 Acyl-nucleotide probes and methods of their synthesis and use in proteomic analysis
04/29/2008US7365173 Using procainamide/peptide ligand affinity chromatography to isolate hydrolase from biological fluid
04/29/2008US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis
04/29/2008US7365168 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
04/29/2008US7365163 Isolation nulceic acid; genetic engineering; screening antagonist; aminobutyric acid receptor; diagnostics for detecting aberrant GABAA receptor epsilon subunit (GABRE) and ET2 expression, therapy of disorders involving ET2 and GABRE
04/29/2008US7365162 Stabilized bioactive peptides and methods of identification, synthesis, and use
04/29/2008US7365161 Mutant tyrosine repressor which does not require tyrosine to induce expression of the tyrosine phenol-lyase gene
04/29/2008US7365160 Membrane protein for use as diagnostic tool in detection and screening of xenobiotics; drug screening
04/29/2008US7365051 Compounds with improved cartilage-inducing and/or bone-inducing activity
04/29/2008US7364903 Cell lines that stably or transiently express a functional umami (T1R1/T1R3) taste receptor
04/29/2008US7364896 Test strips including flexible array substrates and method of hybridization
04/29/2008US7364889 Catalytically active peptides
04/29/2008US7364866 Insecticides; generating immunology response
04/29/2008US7364865 Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1)
04/29/2008CA2242325C Fsh and lh separation and purification process
04/24/2008WO2008048472A2 Methods and compositions for stabilizing prostate specific antigen
04/24/2008WO2008048322A1 Mouse models to study cachexia
04/24/2008WO2008046232A1 Aziridine aldehydes, aziridine-conjugated amino derivatives, aziridine-conjugated biomolecules and processes for their preparation
04/24/2008WO2008015425A3 Mhc oligomers, components thereof, and methods of making the same
04/24/2008WO2007149281A3 Combinatorial library for proteomic investigations
04/24/2008WO2007100506A3 Mass tags for quantitative analyses
04/24/2008US20080097084 Rho Antibody And Tag To Purify Cell Surface Proteins
04/24/2008US20080096812 isolation of low molecular weight proteins from connective tissue of animals, by dissolving in an aqueous solution of alkali compounds, for use in foods and drugs such as anticoagulants or anticholesterol agents
04/24/2008US20080096252 Production of IL-29 from E. coli requires that the aggregated proteins be solubilized from the insoluble inclusion bodies and renatured or refolded; Without renaturation, the specific activity of the recombinant protein will be significantly reduced; higher yields
04/24/2008US20080095914 Novel Vegetable Protein Fractionization Process And Compositions
04/24/2008CA2702605A1 Unprotected amino aldehydes and applications for same
04/24/2008CA2667636A1 Ssl7 mutants and uses therefor
04/24/2008CA2665262A1 Method and compositions for stabilizing prostate specific antigen
04/23/2008EP1914550A1 Peptide-immobilized substrate and method for measuring target protein using the same
04/23/2008EP1913013A2 Truncated oxidized thymosin beta4 and derivatives thereof
04/23/2008EP1791860B1 Purification process for bacterial cytolysin
04/23/2008EP1659919A4 Hemostatic devices containing a protein precipitate
04/23/2008EP1272516B1 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity
04/23/2008EP1182458B1 Method for detecting proteins under mutual interaction
04/23/2008EP0906417B1 Cross-linked protein crystal formulations and their use as catalysts in organic solvents
04/23/2008CN201049218Y Protein crystallizing plate
04/23/2008CN101166754A Process for preparation of mixtures of polypeptides using purified hydrobromic acid
04/23/2008CN101166753A Polymer conjugates of mutated neublastin
04/23/2008CN101165067A Solid phase synthesis method for adrenomedullin (27-52)
04/23/2008CN100383250C Method of expressing bird catching arachinid toxin I and its special carrier
04/23/2008CN100383158C Method and compositions for peptide synthesis
04/23/2008CN100382717C Enhanced oil seed protein recovery
04/22/2008US7361740 Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
04/22/2008US7361739 Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
04/22/2008US7361735 Comprises nucleotide sequences coding lipopolysaccharide induced tumor necrosis factor - alpha factor (LITAF) proteins for use in treatment and prevention of cell proliferative disorders; antitumor agents; immunotherapy
04/22/2008US7361731 Lithography; ink jet printing; for drug delivery
04/22/2008US7361460 Approach to molecular diagnosis of human papillomavirus-related diseases
04/22/2008US7361337 Antibodies against the PRO1754 polypeptides
04/22/2008CA2320190C A method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions
04/22/2008CA2261902C Radiolabeled annexin conjugates whith hexose and a chelator
04/22/2008CA2177575C Method for purifying polypeptides
04/17/2008WO2008044798A1 Agent for introducing protein into cell
04/17/2008WO2008044628A1 Process for production of peptide thioester
04/17/2008WO2008044599A1 Polypeptide having activity of targeting intestine having inflammation, and use thereof
04/17/2008WO2008044379A1 Bone loss model animal
04/17/2008WO2008043847A1 Processing enzymes fused to basic protein tags
04/17/2008WO2008043147A1 Process for generation of protein and uses thereof
04/17/2008WO2008025558A3 Affinity marker comprising a first and a second tag and its use
04/17/2008WO2007144077A3 Improved photostable fret-competent biarsenical-tetracysteine probes based on fluorinated fluoresceins
04/17/2008WO2006119388A8 Methods for the production of peptide having a c-terminal amide
04/17/2008US20080090995 Liquid Chromatography Method
04/17/2008US20080090993 Recombinant cytotoxic lymphocyte-8 for use as regulator of hematopoietic cells; treating infections, allergies and cell proliferative disorders
04/17/2008US20080090776 Obtained from lung cancer patients; cDNA and genomic DNA of a novel fusion polynucleotide of an EML4 gene fused with an ALK gene as kinase (EML4-ALK fusion polynucleotide variant 1); for screening a therapeutic agent for cancer, treating cancer
04/17/2008US20080090282 Use of cell surface displays in yeast cell catalyst supports
04/17/2008US20080090281 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
04/17/2008US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders